BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19540560)

  • 1. Lower- and higher-grade subtypes of diffuse gastric cancer.
    Chiaravalli AM; Klersy C; Tava F; Manca R; Fiocca R; Capella C; Solcia E
    Hum Pathol; 2009 Nov; 40(11):1591-9. PubMed ID: 19540560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
    Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic features and prognosis of gastric cancer in young adults].
    Lu C; Wang ZN; Sun Z; Xu HM
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(19):1468-71. PubMed ID: 19094623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric cancer: correlation between clinicopathological factors and survival of patients. II.
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis.
    Solcia E; Klersy C; Mastracci L; Alberizzi P; Candusso ME; Diegoli M; Tava F; Riboni R; Manca R; Luinetti O
    Virchows Arch; 2009 Sep; 455(3):197-211. PubMed ID: 19672623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
    Lee OJ; Kim HJ; Kim JR; Watanabe H
    Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.
    La Rosa S; Klersy C; Uccella S; Dainese L; Albarello L; Sonzogni A; Doglioni C; Capella C; Solcia E
    Hum Pathol; 2009 Jan; 40(1):30-40. PubMed ID: 18715612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogranin A expression correlates with tumour cell type and prognosis in signet ring cell carcinoma of the stomach.
    Fujiyoshi Y; Eimoto T
    Histopathology; 2008 Feb; 52(3):305-13. PubMed ID: 18269581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of myeloid cell leukemia-1 protein (Mcl-1) expression in human gastric cancer.
    Likui W; Qun L; Wanqing Z; Haifeng S; Fangqiu L; Xiaojun L
    J Surg Oncol; 2009 Oct; 100(5):396-400. PubMed ID: 19582795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy.
    Marrelli D; Pedrazzani C; Corso G; Neri A; Di Martino M; Pinto E; Roviello F
    Ann Surg; 2009 Jul; 250(1):43-50. PubMed ID: 19561483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic and phenotypic features of gastric cancer.
    Fenoglio-Preiser CM; Noffsinger AE; Belli J; Stemmermann GN
    Semin Oncol; 1996 Jun; 23(3):292-306. PubMed ID: 8658213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signet ring cell gastric schwannoma: report of a new distinctive morphological variant.
    Tozbikian G; Shen R; Suster S
    Ann Diagn Pathol; 2008 Apr; 12(2):146-52. PubMed ID: 18325478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis.
    Stock N; Chibon F; Binh MB; Terrier P; Michels JJ; Valo I; Robin YM; Guillou L; Ranchère-Vince D; Decouvelaere AV; Collin F; Birtwisle-Peyrottes I; Gregoire F; Aurias A; Coindre JM
    Am J Surg Pathol; 2009 Dec; 33(12):1850-9. PubMed ID: 19898221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity.
    Humar B; Guilford P
    Cancer Sci; 2009 Jul; 100(7):1151-7. PubMed ID: 19432899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAD2 as a key component of mitotic checkpoint: A probable prognostic factor for gastric cancer.
    Wang L; Yin F; Du Y; Du W; Chen B; Zhang Y; Wu K; Ding J; Liu J; Fan D
    Am J Clin Pathol; 2009 Jun; 131(6):793-801. PubMed ID: 19461085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer.
    Staibano S; Mascolo M; Mancini FP; Kisslinger A; Salvatore G; Di Benedetto M; Chieffi P; Altieri V; Prezioso D; Ilardi G; De Rosa G; Tramontano D
    Histopathology; 2009 Apr; 54(5):580-9. PubMed ID: 19309489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.